Twist Stock Based Compensation from 2010 to 2024

TWST Stock

USD 43.62 0.99 2.22%

Twist Bioscience Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation will likely drop to about 28.3 M in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2017-09-30

Previous Quarter

13.7 M

Current Value

12.3 M

Quarterly Volatility

6.7 M

Covid

Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.

Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Twist Bioscience Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Twist Bioscience's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Twist Stock Based Compensation Regression Statistics

	Arithmetic Mean	17,630,733
	Geometric Mean	5,197,406
	Coefficient Of Variation	133.87
	Mean Deviation	18,406,311
	Median	2,961,000
	Standard Deviation	23,602,962
	Sample Variance	557.1T
	Range	78.8M
	R-Value	0.75
	Mean Square Error	264.3T
	R-Squared	0.56
	Significance	0
	Slope	3,947,407
	Total Sum of Squares	7799.4T

Twist Stock Based Compensation History

	2024	28.3 M
	2023	50.9 M
	2022	30.3 M
	2021	79.7 M
	2020	37 M
	2019	17.1 M
	2018	11.2 M

Other Fundumenentals of Twist Bioscience Corp

Stock Based Compensation To Revenue

Twist Bioscience Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Deferred Long Term Liab	Common Stock
Total Assets		0.98	0.9	0.16	-0.87	-0.84	0.75	-0.89	0.97	0.8	0.41	-0.76	0.9	-0.18	-0.21	0.98	0.72	0.88	0.79	0.89	0.97	-0.25	0.89
Total Stockholder Equity	0.98		0.9	0.23	-0.84	-0.82	0.73	-0.9	0.96	0.76	0.5	-0.86	0.89	-0.36	-0.23	0.97	0.71	0.84	0.75	0.9	0.96	-0.23	0.85
Net Tangible Assets	0.9	0.9		0.0	-0.72	-0.98	0.44	-0.91	0.92	0.93	0.42	-0.84	1.0	-0.33	-0.26	0.86	0.9	0.74	0.93	0.87	0.85	-0.61	0.96
Current Deferred Revenue	0.16	0.23	0.0		-0.42	0.07	0.37	-0.33	0.15	-0.33	0.22	-0.29	0.01	-0.39	0.18	0.34	0.07	-0.16	-0.35	-0.09	0.36	0.29	-0.08
Net Debt	-0.87	-0.84	-0.72	-0.42		0.65	-0.77	0.75	-0.77	-0.58	-0.11	0.59	-0.73	0.07	0.21	-0.92	-0.59	-0.71	-0.54	-0.56	-0.92	0.16	-0.73
Retained Earnings	-0.84	-0.82	-0.98	0.07	0.65		-0.36	0.89	-0.89	-0.95	-0.33	0.73	-0.98	0.2	0.2	-0.79	-0.92	-0.69	-0.95	-0.83	-0.77	0.67	-0.96
Accounts Payable	0.75	0.73	0.44	0.37	-0.77	-0.36		-0.57	0.66	0.33	0.26	-0.43	0.45	-0.02	-0.08	0.77	0.15	0.77	0.31	0.59	0.75	0.29	0.39
Long Term Debt	-0.89	-0.9	-0.91	-0.33	0.75	0.89	-0.57		-0.94	-0.74	-0.57	0.82	-0.92	0.35	0.11	-0.91	-0.84	-0.64	-0.74	-0.83	-0.9	0.44	-0.84
Net Receivables	0.97	0.96	0.92	0.15	-0.77	-0.89	0.66	-0.94		0.81	0.5	-0.79	0.92	-0.25	-0.17	0.94	0.77	0.82	0.81	0.93	0.92	-0.3	0.89
Good Will	0.8	0.76	0.93	-0.33	-0.58	-0.95	0.33	-0.74	0.81		0.22	-0.63	0.93	-0.07	-0.26	0.7	0.83	0.76	1.0	0.82	0.69	-0.68	0.94
Short Term Investments	0.41	0.5	0.42	0.22	-0.11	-0.33	0.26	-0.57	0.5	0.22		-0.61	0.4	-0.56	0.09	0.46	0.35	0.26	0.26	0.64	0.46	-0.09	0.3
Long Term Debt Total	-0.76	-0.86	-0.84	-0.29	0.59	0.73	-0.43	0.82	-0.79	-0.63	-0.61		-0.81	0.77	0.27	-0.77	-0.68	-0.55	-0.63	-0.78	-0.77	0.36	-0.7
Capital Surpluse	0.9	0.89	1.0	0.01	-0.73	-0.98	0.45	-0.92	0.92	0.93	0.4	-0.81		-0.28	-0.23	0.86	0.91	0.73	0.93	0.86	0.86	-0.62	0.96
Total Liab	-0.18	-0.36	-0.33	-0.39	0.07	0.2	-0.02	0.35	-0.25	-0.07	-0.56	0.77	-0.28		0.18	-0.24	-0.23	0.02	-0.08	-0.3	-0.26	0.13	-0.12
Short Long Term Debt	-0.21	-0.23	-0.26	0.18	0.21	0.2	-0.08	0.11	-0.17	-0.26	0.09	0.27	-0.23	0.18		-0.18	-0.03	-0.22	-0.25	-0.15	-0.19	0.17	-0.26
Total Current Assets	0.98	0.97	0.86	0.34	-0.92	-0.79	0.77	-0.91	0.94	0.7	0.46	-0.77	0.86	-0.24	-0.18		0.71	0.8	0.68	0.82	1.0	-0.22	0.84
Short Term Debt	0.72	0.71	0.9	0.07	-0.59	-0.92	0.15	-0.84	0.77	0.83	0.35	-0.68	0.91	-0.23	-0.03	0.71		0.45	0.82	0.66	0.71	-0.77	0.91
Intangible Assets	0.88	0.84	0.74	-0.16	-0.71	-0.69	0.77	-0.64	0.82	0.76	0.26	-0.55	0.73	0.02	-0.22	0.8	0.45		0.75	0.84	0.78	-0.11	0.74
Property Plant Equipment	0.79	0.75	0.93	-0.35	-0.54	-0.95	0.31	-0.74	0.81	1.0	0.26	-0.63	0.93	-0.08	-0.25	0.68	0.82	0.75		0.83	0.67	-0.69	0.93
Net Invested Capital	0.89	0.9	0.87	-0.09	-0.56	-0.83	0.59	-0.83	0.93	0.82	0.64	-0.78	0.86	-0.3	-0.15	0.82	0.66	0.84	0.83		0.8	-0.29	0.8
Net Working Capital	0.97	0.96	0.85	0.36	-0.92	-0.77	0.75	-0.9	0.92	0.69	0.46	-0.77	0.86	-0.26	-0.19	1.0	0.71	0.78	0.67	0.8		-0.24	0.84
Deferred Long Term Liab	-0.25	-0.23	-0.61	0.29	0.16	0.67	0.29	0.44	-0.3	-0.68	-0.09	0.36	-0.62	0.13	0.17	-0.22	-0.77	-0.11	-0.69	-0.29	-0.24		-0.62
Common Stock	0.89	0.85	0.96	-0.08	-0.73	-0.96	0.39	-0.84	0.89	0.94	0.3	-0.7	0.96	-0.12	-0.26	0.84	0.91	0.74	0.93	0.8	0.84	-0.62

Click cells to compare fundamentals

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	50.9 M	28.3 M
Stock Based Compensation To Revenue	0.16	0.24

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Stock Based Compensation from 2010 to 2024

Latest Twist Bioscience's Stock Based Compensation Growth Pattern

Twist Stock Based Compensation Regression Statistics

Twist Stock Based Compensation History

Other Fundumenentals of Twist Bioscience Corp

Twist Bioscience Stock Based Compensation component correlations

About Twist Bioscience Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Twist Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY